Pirtobrutinib, a Non-Covalent (reversible) BTK Inhibitor, in Mantle Cell Lymphoma Patients Previously Treated with a Covalent BTK Inhibitor: Results from a China Phase 2 StudyYuqin Song,Shuhua Yi,Haiyan Yang,Ru Feng,Huiqiang Huang,Qingyuan Zhang,Yanyan Liu,Ye Guo,Huilai Zhang,Liling Zhang, Yijiao Qian, JianKun Zhu,Jun ZhuBLOOD(2023)引用 0|浏览4暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要